CLINICAL_TRIALS
trial_result
· 2019-12-06
Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Study of FX006 in Patients With Osteoarthritis of the Knee [Phase 2]
Summary
Phase 2 pharmacokinetic and pharmacodynamic study of FX006 in patients with osteoarthritis of the knee completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED | Results posted: 2019-12-06